Syngene Leverages Strong Q1 Performance to Accelerate Expansion
Demonstrating financial strength and strategic foresight, Syngene International Limited announced a robust Q1 performance with a 26% YoY increase in…
Tag: Bangalore
Syngene to acquire multi-modal facility from Stelis Biopharma Ltd, adding 20,000 liters of installed biologics drug substance manufacturing capacity, with scope for further expansion, and a high speed, commercial scale, fill-finish unit
Syngene today announced the acquisition of Unit 3 biologics manufacturing facility in Bangalore, India, from Stelis Biopharma Limited (SBL). The…
14-year-old Ethiopian boy undergoes complex kidney transplantation surgery at Aster CMI Hospital
A 14-year-old boy from Ethiopia with stunted growth and bony deformities was given a new lease of life by his…
Nasal Vaccines – What you need to know
The author of this article is Dr. Swati Rajagopal, Consultant – Infectious Disease & Travel Medicine, Aster CMI Hospital, Bangalore…
Long-term implications of arthritis if left untreated
The author of this article is Dr. Chethana D, Consultant – Rheumatology, Aster CMI Hospital, Bangalore Rheumatoid Arthritis (RA) is…